-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
BIOMARIN PHARMACEUTICAL INC quarterly and annual Amortization of Intangible Assets in USD history and change rate from 31 Dec 2011 to 30 Sep 2025.
- BIOMARIN PHARMACEUTICAL INC Amortization of Intangible Assets for the quarter ending 30 Sep 2025 was $4,847,000, a 3.2% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC Amortization of Intangible Assets for the twelve months ending 30 Sep 2025 was $24,191,000, a 50% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC annual Amortization of Intangible Assets for 2024 was $43,257,000, a 30% decline from 2023.
- BIOMARIN PHARMACEUTICAL INC annual Amortization of Intangible Assets for 2023 was $62,211,000, a 7.4% decline from 2022.
- BIOMARIN PHARMACEUTICAL INC annual Amortization of Intangible Assets for 2022 was $67,193,000.